Busey Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $375K | Sell |
2,452
-57
| -2% | -$8.74K | 0.01% | 276 |
|
|
2025
Q4 | $346K | Sell |
2,509
-271
| -10% | -$35.5K | 0.01% | 295 |
|
|
2025
Q3 | $357K | Sell |
2,780
-109
| -4% | -$13.3K | 0.01% | 279 |
|
|
2025
Q2 | $350K | Sell |
2,889
-194
| -6% | -$21.9K | 0.01% | 271 |
|
|
2025
Q1 | $344K | Buy |
3,083
+233
| +8% | +$24.8K | 0.01% | 266 |
|
|
2024
Q4 | $277K | Sell |
2,850
-6
| -0.2% | -$640 | 0.01% | 291 |
|
|
2024
Q3 | $328K | Sell |
2,856
-861
| -23% | -$97.7K | 0.01% | 276 |
|
|
2024
Q2 | $396K | Sell |
3,717
-422
| -10% | -$42.4K | 0.01% | 255 |
|
|
2024
Q1 | $400K | Buy |
4,139
+213
| +5% | +$21.8K | 0.01% | 261 |
|
|
2023
Q4 | $396K | Buy |
3,926
+320
| +9% | +$30.9K | 0.02% | 254 |
|
|
2023
Q3 | $367K | Sell |
3,606
-707
| -16% | -$71.8K | 0.02% | 245 |
|
|
2023
Q2 | $435K | Sell |
4,313
-300
| -7% | -$30K | 0.02% | 247 |
|
|
2023
Q1 | $424K | Sell |
4,613
-18
| -0.4% | -$1.57K | 0.02% | 248 |
|
|
2022
Q4 | $420K | Sell |
4,631
-35
| -0.8% | -$2.95K | 0.02% | 250 |
|
|
2022
Q3 | $355K | Sell |
4,666
-128
| -3% | -$10.6K | 0.02% | 257 |
|
|
2022
Q2 | $405K | Buy |
4,794
+18
| +0.4% | +$1.58K | 0.02% | 254 |
|
|
2022
Q1 | $420K | Sell |
4,776
-593
| -11% | -$51.3K | 0.02% | 266 |
|
|
2021
Q4 | $470K | Sell |
5,369
-254
| -5% | -$21.1K | 0.02% | 261 |
|
|
2021
Q3 | $460K | Buy |
5,623
+867
| +18% | +$78K | 0.02% | 259 |
|
|
2021
Q2 | $433K | Sell |
4,756
-47
| -1% | -$4.18K | 0.02% | 231 |
|
|
2021
Q1 | $411K | Sell |
4,803
-380
| -7% | -$34.1K | 0.02% | 236 |
|
|
2020
Q4 | $490K | Sell |
5,183
-2,320
| -31% | -$203K | 0.03% | 212 |
|
|
2020
Q3 | $653K | Sell |
7,503
-71
| -0.9% | -$6.15K | 0.04% | 196 |
|
|
2020
Q2 | $662K | Sell |
7,574
-838
| -10% | -$72.3K | 0.05% | 188 |
|
|
2020
Q1 | $694K | Sell |
8,412
-21
| -0.2% | -$1.87K | 0.06% | 183 |
|
|
2019
Q4 | $798K | Buy |
8,433
+1,450
| +21% | +$130K | 0.05% | 196 |
|
|
2019
Q3 | $607K | Buy |
6,983
+4,648
| +199% | +$417K | 0.04% | 205 |
|
|
2019
Q2 | $214K | Sell |
2,335
-285
| -11% | -$24.1K | 0.02% | 207 |
|
|
2019
Q1 | $225K | Buy |
+2,620
| New | +$210K | 0.02% | 200 |
|
|
2018
Q1 | – | Sell |
-2,711
| Closed | -$204K | – | 201 |
|
|
2017
Q4 | $204K | Buy |
+2,711
| New | +$205K | 0.03% | 177 |
|
|
2015
Q4 | – | Sell |
-2,614
| Closed | -$215K | – | 210 |
|
|
2015
Q3 | $215K | Hold |
2,614
| – | – | 0.03% | 190 |
|
|
2015
Q2 | $231K | Hold |
2,614
| – | – | 0.03% | 190 |
|
|
2015
Q1 | $231K | Sell |
2,614
-41
| -2% | -$3.64K | 0.03% | 192 |
|
|
2014
Q4 | $220K | Buy |
2,655
+13
| +0.5% | +$1.08K | 0.03% | 193 |
|
|
2014
Q3 | $223K | Hold |
2,642
| – | – | 0.03% | 184 |
|
|
2014
Q2 | $214K | Hold |
2,642
| – | – | 0.03% | 189 |
|
|
2014
Q1 | $201K | Buy |
+2,642
| New | +$193K | 0.03% | 182 |
|
Other funds holding NVS
Busey Bank's NVS Position: Q1 2026 in Review
Busey Bank reduced its Novartis (NVS) stake by 2.3% in Q1 2026, selling an estimated $8.74K and leaving 2,452 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #276.
Busey Bank first reported a position in NVS in Q1 2014 and has held it in 37 quarters since. The position peaked at $798K in Q4 2019. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Busey Bank held 2,452 shares of Novartis worth $375K as of Q1 2026.
- Busey Bank sold 57 Novartis shares in Q1 2026, an estimated $8.74K.
- Novartis made up 0.01% of Busey Bank's portfolio in Q1 2026, its #276 holding.
- Busey Bank first reported a position in Novartis in Q1 2014 and has held it in 37 quarters since.
- Busey Bank's Novartis position peaked at $798K in Q4 2019.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.